The Mind Research Network

A new neuroimaging marker, peak-width of skeletonized mean diffusivity (PSMD), related to cerebral small vessel disease, may identify dementia risk in clinical trials. The study, led by UT Health San Antonio, found PSMD efficiently processes brain images in multi-site dementia studies and is associated with lower general cognition. PSMD's non-invasive, automated, fast, and reliable nature makes it ideal for clinical trial use.